Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Announces Changes to Management Team
May 11th, 2008
Advanced Life Sciences Holdings, Inc. (NASDAQ:ADLS), announced that R. Richard Wieland II, Executive Vice President and Chief Financial Officer, has resigned from the Company to pursue other opportunities. This resignation is effective April 18, 2008. The Board of Directors has appointed John L. Flavin to serve as the Company's Chief Financial Officer. Mr. Flavin will continue in his position as President and Director. "With these management changes, the Company is well positioned to be successful in the next phase of our business as we continue to achieve our Company goals," stated Michael T. Flavin, Ph.D., Chief Executive Officer of the Company. Dr. Flavin added: "We...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-11)
|
